In March 2026, Eli Lilly filed a petition with the U.S. Supreme Court challenging the constitutionality of qui tam. The case stems from a 2014 whistleblower lawsuit brought by Ronald Streck, a lawyer and pharmacist who accused Eli Lilly of short-changing Medicaid by concealing retroactive drug price increases and failing to rebate the program on the higher prices. A federal jury found in Streck’s favor in August 2022 and awarded $61 million in damages, which automatically tripled to $183 million under the False Claims Act. The 7th U.S. Circuit Court of Appeals upheld that verdict in September 2025.
Eli Lilly’s petition argued that allowing private citizens to prosecute fraud cases on the government’s behalf is unconstitutional: “unaccountable and uncontrollable private prosecutors pursuing their own ends in the name of the United States is fundamentally incompatible with our Constitution,” the company said in its filing. The theory is that whistleblowers exercise executive power without being accountable to the president.
The Supreme Court denied the petition on May 18, 2026. This was a significant win for whistleblowers and for the False Claims Act’s continued reach.
If SCOTUS kills qui tam, does modern whistleblower enforcement collapse?
Modern whistleblower enforcement wouldn’t collapse entirely, but it would take a serious hit. Qui tam provisions are the engine behind billions of dollars in annual fraud recovery, and eliminating them would leave the government far more dependent on its own limited resources to detect and prosecute corporate misconduct. For now, the immediate threat has passed: the U.S. Supreme Court denied Eli Lilly’s petition challenging these provisions on May 18, 2026. But the legal fight isn’t over.
Eli Lilly’s challenge is part of a broader corporate push to limit the reach of the False Claims Act. The whistleblower lawyers at Bracker & Marcus LLC handle fraud and False Claims Act cases exclusively, and we’ll help you break down what this challenge means and what it could mean for people who know about fraud and are considering coming forward.
Why are qui tam whistleblower cases so important to fraud enforcement?
Under the False Claims Act, a private individual who discovers that a company is defrauding the federal government can file a lawsuit on the government’s behalf and share in whatever is recovered.
The numbers show how much this matters. From October 2024 through September 2025, the federal government recovered more than $6.8 billion in False Claims Act settlements and judgments, with whistleblowers receiving more than $330 million in awards, according to the U.S. Department of Justice. The vast majority of those recoveries started with a whistleblower who had inside knowledge the government didn’t.
That’s the core of why qui tam works. Companies go to great lengths to conceal fraud, and insider information is often the only way enforcement agencies can see past the cover. Without qui tam protections, whistleblowers have far less incentive to come forward, and the government loses its most reliable source of intelligence about corporate misconduct.
How much of modern fraud enforcement depends on whistleblowers?
The short answer is: a lot. Whistleblowers supply more than just a tip; they often provide the documentary evidence and firsthand accounts that allow federal prosecutors to build cases they otherwise couldn’t. Without access to internal records, communications, and pricing data, fraud schemes involving Medicare, Medicaid, defense contracts, and other government programs can run for years undetected.
There’s also a real deterrent effect worth considering. The knowledge that an employee can come forward (and be protected and financially rewarded for doing so) changes corporate behavior. Companies that might otherwise push the limits of billing or regulatory compliance face a much harder calculation when their own people can hold them accountable.
What happens if the Supreme Court limits or removes qui tam actions?
Even though Eli Lilly’s petition was denied, the question isn’t closed. If a future ruling were to significantly limit or eliminate qui tam provisions, the government would have to rely on its own investigators to detect fraud, which is a resource-intensive process that frequently misses sophisticated internal schemes that whistleblowers are best positioned to expose.
Companies engaged in fraud would face a dramatically reduced risk of detection, and the taxpayers and program beneficiaries harmed by that fraud would have no private avenue to force accountability.
It would also likely take years for Congress to respond with replacement legislation, and there’s no guarantee any substitute would carry the same scope or whistleblower protections as the current law.
Would whistleblower enforcement disappear or just change?
It would change significantly, though it wouldn’t vanish entirely. Other avenues would still exist: state-level False Claims Acts, which many states have modeled on the federal version, could continue to support actions involving state programs, including Medicaid. The SEC Whistleblower Program covers securities fraud, and the IRS Whistleblower Office handles tax fraud, though neither reaches the broad range of healthcare and government contractor fraud that the False Claims Act addresses.
If qui tam were eliminated, Congress would face pressure to fill the gap with new legislation, but passing and implementing a replacement takes time, and there’s no guarantee any substitute would carry the same scope or protections. Whistleblowers who had information about federal fraud would, in the meantime, have considerably fewer options and considerably more risk.
What should whistleblowers and companies watch right now?
The Eli Lilly petition isn’t the only challenge to qui tam working through the courts. In a separate case, U.S. District Judge Kathryn Mizelle ruled in September 2024 that qui tam provisions unconstitutionally allow private parties to exercise executive power without presidential oversight. That case is now before the 11th U.S. Circuit Court of Appeals, which heard oral arguments in December 2025. A ruling from the 11th Circuit could set the stage for another Supreme Court petition and potentially a different outcome.
If you’re aware of fraud against the federal government and weighing whether to come forward, the current environment is unsettled enough that timing and legal strategy matter more than ever.
Speak with a whistleblower lawyer about your options under the False Claims Act
The legal landscape around qui tam is shifting, and what it means for your specific situation depends on the nature of the fraud, the industry involved, and where any pending legal challenge stands when your case is filed. At Bracker & Marcus LLC, we focus deeply on fraud and False Claims Act cases. That means you’re working with attorneys who know this area thoroughly and follow every development that could affect your claim.
If you think you may have a qui tam case, contact us online to schedule a free consultation, or call (770) 988-5035 today.